Do the Symptoms of Chronic Constipation Improve With a Primary Care Programme Based on Behavioural Re-education and Abdominal Massage?

Do the Symptoms of Chronic Constipation Improve With a Primary Care Programme Based on Behavioural Re-education and Abdominal Massage? A Randomised Control Trial

Constipation is one of the most common digestive problems in today's society. In Spain, it is estimated that this condition affects between 12% and 20% of the population, being more frequent in women, contributing considerably to the quality of life, to the increase of medical visits and to high costs for the health system. The objectives of the study are to reduce the rate of constipation and laxative use in the short term with a structured rehabilitation programme consisting of abdominal massage therapy and behavioural re-education, to improve the quality of life of these patients, and to assess whether the proposed treatment is effective in the short and medium term.

Study Overview

Detailed Description

Background: Constipation is one of the most common digestive problems in today's society. In Spain, it is estimated that this condition affects between 12% and 20% of the population, being more frequent in women, contributing considerably to the quality of life, to the increase of medical visits and to high costs for the health system. The objectives of the study are to reduce the rate of constipation and laxative use in the short term with a structured rehabilitation programme consisting of abdominal massage therapy and behavioural re-education, to improve the quality of life of these patients, and to assess whether the proposed treatment is effective in the short and medium term.

Method: Randomised clinical trial. Participants: people with constipation in the region of L'Anoia, Catalonia. There will be 3 groups: the control group (CG), behavioural intervention group (BIG) and behavioural intervention and massage group (BIMG). Constipation will be assessed with the Bristol scale, Rome IV Criteria and the number of laxatives; and quality of life with the CVE-20 Questionnaire.

Participants will be proposed from Primary Care Centres in the region of L'Anoia, Catalonia, Spain.

Inclusion criteria:

  • Having been diagnosed with primary constipation using Rome IV Criteria(11), of more than three months' duration.
  • Understanding Catalan, Spanish or English.

Exclusion criteria:

  • Having constipation secondary to neurogenic, metabolic, endocrine or postoperative diseases.
  • Having constipation secondary to medication for other pathologies, the medication list for which can be found in the annex.
  • Having any type of open abdominal and/or anal wound, such as a recent abdominal scar or anal fissure.
  • Meeting any absolute contraindication criteria for the use of abdominal massage therapy, such as an unstable fracture requiring absolute rest and immobilisation, pregnancy or active oncological procedures.
  • Suffering from some type of cognitive, psychiatric or neurological alteration that does not allow to understand the project.

Discussion: Research is needed on conservative, non-pharmacological treatment to try to reduce one of the main conditions affecting public health, and thus reduce the possible illnesses associated with constipation and reduce costs to the health system.

Study Type

Interventional

Enrollment (Estimated)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Igualada, Barcelona, Spain, 08700
        • Cristina Segura Bayona

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Having been diagnosed with primary constipation using Rome IV Criteria(11), of more than three months' duration.
  • Understanding Catalan, Spanish or English.

Exclusion Criteria:

  • Having constipation secondary to neurogenic, metabolic, endocrine or postoperative diseases.

    • Having constipation secondary to medication for other pathologies, the medication list for which can be found in the annex.
    • Having any type of open abdominal and/or anal wound, such as a recent abdominal scar or anal fissure.
    • Meeting any absolute contraindication criteria for the use of abdominal massage therapy, such as an unstable fracture requiring absolute rest and immobilisation, pregnancy or active oncological procedures.
    • Suffering from some type of cognitive, psychiatric or neurological alteration that does not allow to understand the project.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Habitual treatment
Experimental: behavioural intervention group
Conductual treatment
change of habits
Experimental: behavioural intervention and massage group
Conductual and abdominal massage treatment
change of habits + auto abdominal massage

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Degree of constipation
Time Frame: Day 0, Month 3, Month 6
Degree of constipation with Rome IV Criteria
Day 0, Month 3, Month 6
Stool characteristics
Time Frame: Day 0, Month 3, Month 6
Stool characteristics with the Bristol Scale
Day 0, Month 3, Month 6
Quality of life focused on patients with constipation
Time Frame: Day 0, Month 3, Month 6
Quality of life focused on patients with constipation with the CVE-20 questionnaire from an emotional, physical and social viewpoint.
Day 0, Month 3, Month 6
The number of laxatives taken by each participant
Time Frame: Month 3, Month 6
The number of laxatives taken by each participant with an accounting schedule.
Month 3, Month 6

Secondary Outcome Measures

Outcome Measure
Time Frame
Other patient characteristics such as sex, age, previous conditions, and level of physical activity with the VREM questionnaire.
Time Frame: Day 0, Month 3, Month 6
Day 0, Month 3, Month 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2024

Primary Completion (Estimated)

December 28, 2026

Study Completion (Estimated)

December 28, 2026

Study Registration Dates

First Submitted

March 18, 2024

First Submitted That Met QC Criteria

April 5, 2024

First Posted (Actual)

April 11, 2024

Study Record Updates

Last Update Posted (Actual)

April 11, 2024

Last Update Submitted That Met QC Criteria

April 5, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Constipation Chronic Idiopathic

Clinical Trials on change of habits

3
Subscribe